51. Therapeutic Potential of AAV1-Rheb(S16H) Transduction Against Alzheimer’s Disease
- Author
-
Kea Joo Lee, Sang Ryong Kim, Sehwan Kim, Michiko Nakamura, Gyeong Joon Moon, Il-Sung Jang, and Min-Tae Jeon
- Subjects
rheb(s16h), neurotrophic signaling ,lcsh:Medicine ,Tropomyosin receptor kinase B ,Ciliary neurotrophic factor ,Hippocampal formation ,Neuroprotection ,Article ,03 medical and health sciences ,0302 clinical medicine ,Neurotrophic factors ,Medicine ,030304 developmental biology ,cognitive impairment ,0303 health sciences ,biology ,business.industry ,β-amyloid ,lcsh:R ,Long-term potentiation ,alzheimer’s disease ,General Medicine ,nervous system ,biology.protein ,business ,Neuroscience ,030217 neurology & neurosurgery ,RHEB ,Neurotrophin - Abstract
We recently reported that adeno-associated virus serotype 1-constitutively active Ras homolog enriched in brain [AAV1-Rheb(S16H)] transduction of hippocampal neurons could induce neuron-astroglia interactions in the rat hippocampus in vivo, resulting in neuroprotection. However, it remains uncertain whether AAV1-Rheb(S16H) transduction induces neurotrophic effects and preserves the cognitive memory in an animal model of Alzheimer&rsquo, s disease (AD) with characteristic phenotypic features, such as &beta, amyloid (A&beta, ) accumulation and cognitive impairments. To assess the therapeutic potential of Rheb(S16H) in AD, we have examined the beneficial effects of AAV1-Rheb(S16H) administration in the 5XFAD mouse model. Rheb(S16H) transduction of hippocampal neurons in the 5XFAD mice increased the levels of neurotrophic signaling molecules, including brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF), and their corresponding receptors, tropomyosin receptor kinase B (TrkB) and CNTF receptor &alpha, subunit (CNTFR&alpha, ), respectively. In addition, Rheb(S16H) transduction inhibited A&beta, production and accumulation in the hippocampus of 5XFAD mice and protected the decline of long-term potentiation (LTP), resulting in the prevention of cognitive impairments, which was demonstrated using novel object recognition testing. These results indicate that Rheb(S16H) transduction of hippocampal neurons may have therapeutic potential in AD by inhibiting A&beta, accumulation and preserving LTP associated with cognitive memory.
- Published
- 2019